Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...
16hon MSNOpinion
What a minefield labels have made for us | Opinion
A friend comes for dinner with an additional guest, who also brought with the notion that my beliefs need to be set straight.
Press Trust of India on MSN
Cipla Health welcomes FSSAI's new labelling rules for 'ORS', reinforces Prolyte ORS as the #AsliORS
ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from the Food Safety and Standards ...
This important work employed a recent, functional muscle network analysis for evaluating rehabilitation outcomes in post-stroke patients. While the research direction is relevant and suggests the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results